PharmaCyte Biotech Inc (PMCB) stock news · $8.6M cap
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
This PMCB news page leads with what PharmaCyte Biotech Inc filed — not a scraped headline mill.
No cached 8-K sentence for PMCB yet. We will not pad this page with generic market recap.
Latest reported PMCB revenue for 2026-04-30 was $0. Net income was -$19.4M. PMCB currently screens at market cap $8.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PMCB stock page; for the tape open the quote page.
PMCB stock news FAQ
What is PMCB's latest net income?
Latest cached PharmaCyte Biotech Inc (PMCB) net income was -$19.4M. Statements: https://lician.com/financials/pmcb
What is PMCB's market cap?
PharmaCyte Biotech Inc (PMCB) market cap is $8.6M on the latest cached fundamentals snapshot.
What kind of company is PMCB?
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Where is PMCB stock news listed?
Cached stock news for PharmaCyte Biotech Inc (PMCB) is listed at https://lician.com/news/pmcb. Filings: https://lician.com/sec/pmcb
Not investment advice.